Lupin Ltd.

View in App
1097.05 -31.90 ▼-2.8%

22 September 2023, 04:01:00 PM
Volume: 37,145

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lupin.com
Market Cap 49,940.13 Cr.
Enterprise Value(EV) 52,891.05 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 21.34 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 51.41 Trailing Twelve Months Ending 2023-06
Industry PE 37.50 Trailing Twelve Months Ending 2023-06
Book Value / Share 280.50 Trailing Twelve Months Ending 2023-06
Price to Book Value 3.91 Calculated using Price: 1,097.05
Dividend Yield 0.36 Period Ending 2023-03
No. of Shares Subscribed 45.52 Cr. 455,221,984 Shares
FaceValue 2
About Lupin Ltd.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. Lupin is recognised as one of the world's largest manufacturers of Tuberculosis drugs. The company have significant market share across multiple therapy areas such as Cardiovascular (prils and statins), Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro Intestinal (GI), Anti-Infective (AI) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). To add to this, the company has proud to maintain over the years its global leadership positions in other therapy areas such as Anti-TB and Cephalosporin.

Lupin Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Lupin Ltd. Performance

View details >>
1 Day
-2.83%
1 Week
-4.67%
1 Month
+0.56%
3 Month
+28.78%
6 Month
+66.38%
1 Year
+65.41%
2 Year
+16.74%
5 Year
+23.30%
10 Year
+26.45%

Lupin Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 31.09 22.85 21.05 1.91 3.88 -3.09 9.47 -11.79 3.68
Return on Capital Employed (%) 40.30 24.42 18.57 3.54 7.97 5.45 9.71 -7.11 6.06
Return on Assets (%) 21.08 12.84 10.60 0.99 1.97 -1.54 5.09 -6.70 2.01

Lupin Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 6,932 8,874 11,163 13,498 13,577 13,742 12,537 13,803 12,153 12,465
Non Curr. Liab. 507 426 6,032 6,447 6,876 7,296 3,003 1,136 1,153 992
Curr. Liab. 2,630 3,729 5,061 6,121 5,096 6,130 9,225 8,436 8,276 9,265
Minority Int. 67 24 32 35 40 47 44 55 69 78
Equity & Liab. 10,135 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651 22,800
Non Curr. Assets 4,035 5,221 12,402 14,147 13,379 13,362 9,396 9,444 9,194 10,349
Curr. Assets 6,100 7,832 9,887 11,953 12,210 13,854 15,413 13,986 12,458 12,451
Misc. Exp. not W/O
Total Assets 10,135 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651 22,800

Lupin Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 12,770 14,139 17,494 15,804 14,665 15,375 15,163 16,405 16,642 17,712
Other Income 240 185 107 150 333 484 136 214 151 93
Total Income 13,010 14,324 17,601 15,955 14,998 15,859 15,299 16,619 16,793 17,805
Total Expenditure -9,150 -10,454 -13,001 -12,657 -12,104 -13,020 -12,596 -16,190 -14,921 -15,292
PBIDT 3,859 3,871 4,600 3,298 2,894 2,839 2,703 429 1,871 2,513
Interest -10 -59 -153 -204 -302 -363 -141 -143 -274 -317
Depreciation -435 -487 -912 -1,086 -846 -970 -887 -1,659 -881 -923
Taxation -970 -1,059 -979 -288 -888 -1,157 -449 -137 -269 -285
Exceptional Items -1,464 -340 -752
PAT 2,444 2,270 2,565 255 521 -400 1,228 -1,509 448 988
Minority Interest -41 -9 -7 -7 -9 0 -11 -19 -18 -16
Share Associate 4
Other Related Items
Consolidated Net Profit 2,403 2,261 2,557 251 607 -269 1,217 -1,528 430 971
Adjusted EPS 53 50 57 6 13 -6 27 -34 9 21

Lupin Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 2,004 2,733 -382 4,114 1,751 1,666 1,469 1,822 367 1,897
Cash Fr. Inv. -859 -1,055 -6,962 -2,527 470 -3,282 1,107 -1,240 1,292 -1,287
Cash Fr. Finan. -857 -197 5,836 433 -1,492 744 -891 -1,885 -1,572 -337
Net Change 288 1,482 -1,508 2,019 729 -872 1,685 -1,303 87 273
Cash & Cash Eqvt 607 2,108 780 2,799 1,416 544 2,229 926 1,013 1,265

Lupin Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 46.84 46.83 46.81 46.78 47.10 47.11 47.10 47.08 47.07
Public 53.16 53.17 53.19 53.22 52.90 52.89 52.90 52.92 52.93
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Lupin Ltd. Announcements

View details >>
Fri, 22 Sep 2023
Announcement under Regulation 30 (LODR)-Acquisition
Lupin Acquires Five Brands from Menarini.
Fri, 22 Sep 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin Acquires Five Brands from Menarini.
Mon, 18 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate by the shareholder.

Lupin Ltd. Technical Scans

View details >>
Fri, 22 Sep 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low

Lupin Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,508.75 1,131.60 -1.3%
Divi's Laboratories Ltd. 98,393.27 3,708.40 -1.0%
Cipla Ltd. 95,796.29 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. 92,004.31 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. 71,703.97 5,003.05 -0.3%
Mankind Pharma Ltd. 70,167.07 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. 62,653.02 1,853.55 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.19 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 66.64 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 30.73 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.48 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 107.60 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 54.74 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.79 1,853.55 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 7.50 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 3.93 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.75 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.47 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 5.73 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.54 1,853.55 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,853.55 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,853.55 -1.1%

Lupin Ltd. FAQ's

What is Lupin share price?
Can I buy Lupin shares now?
What is the Dividend Yield of Lupin?
What is the Market Cap of Lupin?
What are the key metrics to analyse Lupin?
What is the 52 Week High and Low of Lupin?
What is the trend of Lupin share price?